| Biotechnology Industry | Healthcare Sector | Mr. Mark Andrew Upsdell CEO | CNSX Exchange | - ISIN |
| CA Country | - Employees | - Last Dividend | 16 Feb 2018 Last Split | - IPO Date |
Rapid Dose Therapeutics Corp. is a pioneering life sciences company based in Burlington, Canada, specializing in innovative drug delivery technologies. The company is committed to improving health outcomes by providing advanced solutions for the rapid release of active molecules into the bloodstream. Their target market encompasses the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries, for whom they also offer product innovation, production, and consultation services. Through its cutting-edge approach, Rapid Dose Therapeutics aims to enhance the bioavailability of medications, resulting in faster and more efficient drug absorption.